'China is hungry,' as drug innovation push continues
Certara’s new consulting firm will rely on modeling and simulation expertise to expedite the drug development process, as China commits to increasing innovation.
Certara’s new consulting firm will rely on modeling and simulation expertise to expedite the drug development process, as China commits to increasing innovation.
Catalent will pursue strategic acquisitions and licensing in 2016, said VP Marketing & Strategy Elliott Berger, noting growth areas include complex delivery technologies and specialised logistics.
Domainex and Cresset have partnered to offer small molecule drug discovery services that combine their respective strengths in chemistry in biology.
New information, including Bial’s clinical protocol document have emerged over the past week, providing new insight into the Biotrial tragedy.
Clinical trial participants willingly put themselves at risk, so a committee is proposing that data sharing be mandated before manuscript publication is considered.
A Zika vaccine is a long way off according to a UK academic who suggested vaccines for related viruses could be used as delivery vectors to accelerate development.